6/3/2013 9:05:25 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MORRIS PLAINS, N.J., June 3, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that 6 presentations, of which 3 are oral presentations, will be given at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 Annual Meeting, scheduled for June 8 - 12, 2013, in Vancouver, BC, Canada.
Help employers find you! Check out all the jobs and post your resume.
comments powered by